BioNTech begins development of an adapted Covid vaccine

BioNTech begins developing a new Covid vaccine adapted to intercept the new variants. According to what reported by Bloomberg, the German pharma company has issued a statement via email in which it confirms that a vaccine may be needed to combat new variants of the virus such as Omicron.

BioNTech has developed one of the vaccines to prevent COVID-19 with Pfizer.